What is Humanscape?
Humanscape is a digital healthcare innovator operating two key platforms: RareNote, dedicated to broadening treatment access for individuals with rare and intractable diseases, and Mamitalk, a comprehensive resource for pregnancy and parenting support. The company's focus on specialized health challenges and family well-being highlights its commitment to leveraging technology for impactful patient and user solutions within the healthcare ecosystem.
How much funding has Humanscape raised?
Humanscape has raised a total of $3.8M across 1 funding round:
Other Financing Round
$3.8M
Other Financing Round (2025): $3.8M with participation from Korea Investment Partners, Naver, and Daewoong Investment
Key Investors in Humanscape
Korea Investment Partners
Korea Investment Partners is a leading South Korean financial holding company with a strong focus on investment banking and capital investment, likely bringing strategic financial expertise to Humanscape's growth.
Naver
Naver Corporation, a major South Korean internet conglomerate, offers extensive digital service capabilities and a vast user network, suggesting a strategic partnership for Humanscape's digital platform expansion and market penetration.
Daewoong Investment
Daewoong Investment Inc, operating within the venture capital and private equity sector, is likely providing crucial financial backing and strategic guidance to support Humanscape's development and market initiatives.
What's next for Humanscape?
With a substantial enterprise-level funding context, Humanscape is poised for significant scaling and development. The recent strategic investment is expected to fuel advancements in its existing platforms and potentially explore new avenues for digital health solutions. This backing will likely enable Humanscape to enhance its market reach, deepen its research capabilities, and solidify its position as a leader in providing innovative care and support for specific health needs and life stages.
See full Humanscape company page
